Shark-Liver Substance May Slow Growth Of Brain Tumors

May 15, 1996

Results of Johns Hopkins animal studies show that a natural shark substance nearly stops the growth of new blood vessels that nourish solid brain tumors.

The results suggest that the substance, squalamine, named for the shark genus Squalus, may find a role with chemotherapy, radiation and surgery in treating brain cancer and other solid tumors in people, say scientists from Hopkins and Magainin Pharmaceuticals, which processes squalamine and funded the studies.

Hopkins scientists added squalamine, a hormone-like chemical concentrated in the liver of the dogfish shark, and a growth factor to lab dishes containing central nervous system blood vessel cells from cows and squalamine alone to lab dishes containing human, rabbit or rat solid brain tumor cells. The blood vessel cells' rate of growth fell by up to 83 percent after two days, while the tumor cells treated with squalamine were unaffected. Results of a second study showed that time-release capsules containing squalamine slowed the growth of new blood vessels caused by tumors in rabbits' eyes by up to 43 percent after three weeks.

The studies are to be presented today at the American Association of Neurological Surgeons' annual meeting in Minneapolis, Minn.

Uncontrolled growth of blood vessels fuels the runaway cell growth of malignant tumors. Other investigators also are exploring natural shark substances for use against human diseases, but this is believed to be the first evidence that squalamine may work against brain cancer. Squalus sharks' livers produce an oil used in manufacturing drugs, and small amounts of squalamine are found in shark cartilage.

Squalamine dramatically slowed blood vessel cell growth without damaging healthy cells, according to Henry Brem, M.D., co-author of the studies and director of neurosurgical oncology at Hopkins and Allen K. Sills, M.D., lead author and a Hopkins neurosurgery resident.

"We're encouraged by these initial findings," says Brem, who successfully uses time-release polymer discs to deliver a different anti-cancer drug directly to the brain to fight malignant tumors in people.

Pending further lab research, clinical studies with malignant gliomas, the most common and deadly brain tumor, may begin in 1997, according to Michael A. Zasloff, M.D., Ph.D., executive vice president of Magainin.

Brain cancer causes a substance known as vascular endothelial growth factor (VEGF) to bind to cells lining brain blood vessels. VEGF causes the endothelial cells to multiply uncontrollably, thereby forming new blood vessels that allow the tumor to grow. Hopkins and Magainin scientists last week reported that squalamine appears to work by blocking a protein in endothelial cell membranes that is activated by VEGF and other growth factors.

The studies' other authors were Darin S. Epstein, B.A., and Eric P. Sinos, M.D., of Hopkins and Delwood Collins, Ph.D., and Jon Williams, Ph.D., of Magainin.
-end-


Johns Hopkins Medicine

Related Blood Vessels Articles from Brightsurf:

Biofriendly protocells pump up blood vessels
In a new study published today in Nature Chemistry, Professor Stephen Mann and Dr Mei Li from Bristol's School of Chemistry, together with Associate Professor Jianbo Liu and colleagues at Hunan University and Central South University in China, prepared synthetic protocells coated in red blood cell fragments for use as nitric oxide generating bio-bots within blood vessels.

Specific and rapid expansion of blood vessels
Upon a heart infarct or stroke, rapid restoration of blood flow, and oxygen delivery to the hypo perfused regions is of eminent importance to prevent further damage to heart or brain.

Flexible and biodegradable electronic blood vessels
Researchers in China and Switzerland have developed electronic blood vessels that can be actively tuned to address subtle changes in the body after implantation.

Lumpy proteins stiffen blood vessels of the brain
Deposits of a protein called ''Medin'', which manifest in virtually all older adults, reduce the elasticity of blood vessels during aging and hence may be a risk factor for vascular dementia.

Cancer cells take over blood vessels to spread
In laboratory studies, Johns Hopkins Kimmel Cancer Center and Johns Hopkins University researchers observed a key step in how cancer cells may spread from a primary tumor to a distant site within the body, a process known as metastasis.

Novel function of platelets in tumor blood vessels found
Scientists at Uppsala University have discovered a hitherto unknown function of blood platelets in cancer.

Blood vessels can make you fat, and yet fit
IBS scientists have reported Angiopoietin-2 (Angpt2) as a key driver that inhibits the accumulation of potbellies by enabling the proper transport of fatty acid into general circulation in blood vessels, thus preventing insulin resistance.

Brothers in arms: The brain and its blood vessels
The brain and its surrounding blood vessels exist in a close relationship.

Feeling the pressure: How blood vessels sense their environment
Researchers from the University of Tsukuba discovered that Thbs1 is a key extracellular mediator of mechanotransduction upon mechanical stress.

Human textiles to repair blood vessels
As the leading cause of mortality worldwide, cardiovascular diseases claim over 17 million lives each year, according to World Health Organization estimates.

Read More: Blood Vessels News and Blood Vessels Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.